Innovative therapies in Ewing Sarcoma.

Adv Anat Pathol

*Molecular Pathology Program, Institute of Biomedical Research of Salamanca-Centro de Investigación del Cáncer, Centro de Investigación del Cancér (IBSAL-CIC), Campus Miguel de Unamuno S/N, Salamanca †Pathology Department, Hospital Universitario Virgen del Rocio-IBiS, Sevilla, Spain.

Published: January 2014

Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000003DOI Listing

Publication Analysis

Top Keywords

ewing sarcoma
8
innovative therapies
4
therapies ewing
4
sarcoma ewing
4
sarcoma developmental
4
developmental tumor
4
tumor characterized
4
characterized balanced
4
balanced chromosomal
4
chromosomal translocations
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!